Cataract Surgery Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, UK, Germany, Japan, China - Size and Forecast 2024-2028

Cataract Surgery Devices Market Size 2024-2028

The cataract surgery devices market size is forecast to increase by USD 1.86 billion, at a CAGR of 5.21% between 2023 and 2028.

• The market is driven by the increasing prevalence of cataracts, primarily due to the aging population. As people grow older, the likelihood of developing cataracts increases, leading to a significant demand for cataract surgery. Furthermore, medical tourism is on the rise, with patients traveling to countries with lower costs for cataract surgery, expanding the market's reach. However, challenges persist in this market. The high cost of cataract surgeries and insufficient insurance coverage limit access to this essential procedure for many individuals, creating a barrier to growth.
• Companies operating in this market must navigate these challenges to capitalize on the opportunities presented by the increasing demand for cataract surgery. Strategies such as offering affordable pricing and collaborating with insurance providers could help overcome these obstacles and expand market share.

What will be the Size of the Cataract Surgery Devices Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample

The market is characterized by continuous innovation and evolution, driven by advancements in technology and increasing demand for improved patient outcomes. Astigmatism correction, patient selection criteria, intraocular lens (IOL) power calculation, implant stability, and advanced imaging techniques are integral components of cataract surgery, with ongoing research and development focusing on enhancing their precision and effectiveness. Phacoemulsification technology, a key procedure in cataract surgery, has seen advancements in phaco energy settings and aspiration systems, enabling greater surgical precision and reducing the risk of complications. IOL material properties, such as accommodative and toric options, are also under constant scrutiny to optimize visual acuity improvement and address individual patient needs.

Surgical technique variations, including capsulorhexis techniques and microvacuum aspiration, contribute to the evolving landscape of cataract surgery. Prevention of endophthalmitis and postoperative inflammation, as well as the development of surgical planning software and glaucoma management tools, further expand the market's scope. Intraocular lens implantation, a critical aspect of cataract surgery, is influenced by IOL power calculation, implant stability, and surgical precision metrics. Ultrasound technology and irrigation systems play essential roles in ensuring accurate IOL positioning and maintaining a clean surgical environment. Wound sealing devices and visual outcome assessment tools are also essential components, contributing to overall surgical success and patient satisfaction.

The market is a dynamic and ever-changing landscape, with ongoing research and development addressing the needs of various sectors and patient populations. The integration of advanced imaging techniques, accommodative IOLs, and surgical precision metrics continues to drive innovation and improve patient outcomes.

How is this Cataract Surgery Devices Industry segmented?

The cataract surgery devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Product
  • Intraocular lens (IOLs)
  • Phacoemulsification devices
  • Ophthalmic viscosurgical devices (OVDs)
  • Femtosecond lasers
• End-user
  • Hospitals and clinics
  • Ophthalmology centers
• Geography
  • North America
    • US
  • Europe
    • Germany
    • UK
  • APAC
    • China
    • Japan
  • Rest of World (ROW)

By Product Insights

The intraocular lens (iols) segment is estimated to witness significant growth during the forecast period.

Intraocular lenses (IOLs) are essential medical devices implanted during cataract surgery to replace the natural lens, addressing vision loss from cataracts or myopia. Monofocal IOLs, the standard option, only correct one type of vision loss, necessitating the use of glasses. In contrast, premium IOLs, such as multifocal, toric, and accommodative IOLs, correct multiple vision issues, thereby eliminating the need for glasses. Advanced IOLs, including HD IOLs, offer rapid visual acuity improvement with minimal side effects. companies focus on manufacturing innovative IOLs with enhanced efficiency and safety. Phacoemulsification technology, a common cataract surgery method, utilizes ultrasound energy to fragment the lens, enabling easy removal.

Aspiration systems facilitate the removal of lens fragments. Nuclear fragmentation techniques and iol material properties are critical considerations to ensure effective lens fragmentation. Surgical technique variations, such as capsulorhexis techniques and phaco energy settings, impact the success of cataract surgery. Endophthalmitis prevention, a crucial aspect of cataract surgery, is addressed through advanced imaging techniques, surgical precision metrics, and wound sealing devices. Intraoperative complications, such as postoperative inflammation, are minimized through proper patient selection criteria, iol power calculation, and implant stability. Lens material biocompatibility, a significant factor in IOL success, is ensured through rigorous testing. Irrigation systems and surgical microscope systems facilitate the surgical process.

Surgical planning software and glaucoma management tools assist surgeons in optimizing surgical outcomes. Surgical training simulators enable surgeons to practice and perfect their skills, ensuring optimal patient care.

Request Free Sample

The Intraocular lens (IOLs) segment was valued at USD 3.06 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 42% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Request Free Sample

In North America, the rising per capita healthcare expenditure, as reported by the World Bank Group, is leading to an increased adoption of cataract surgery devices among individuals with visual impairment due to cataracts. Market growth is driven by several factors, including enhanced healthcare infrastructure, government initiatives, funding for eye diseases and vision care, favorable reimbursement policies in developed countries like the US and Canada, and the expanding presence of global manufacturers producing cataract surgery equipment. Improved phacoemulsification technology, such as lens fragmentation techniques and advanced imaging, enables more precise cataract removal and implantation of multifocal IOLs for visual acuity improvement.

Surgical technique variations, including capsulorhexis techniques and accommodative IOLs, cater to individual patient needs. Aspiration systems and irrigation solutions ensure efficient and safe surgeries, while endophthalmitis prevention measures reduce the risk of postoperative complications. Surgical microscope systems and intraoperative complications monitoring tools enhance surgical precision, and wound sealing devices promote corneal wound healing. IOL power calculation software and implant stability assessment technologies ensure accurate implantation and long-term success. Glaucoma management solutions and surgical training simulators further support the market's growth. Lens material biocompatibility and accommodative iols address patient preferences and refractive error correction needs. Ultrasound technology and microvacuum aspiration systems facilitate efficient cataract removal, while toric IOLs correct astigmatism.

Surgical planning software and postoperative inflammation management tools contribute to improved patient outcomes. In summary, the market in North America is experiencing significant growth due to increasing healthcare expenditures, favorable market conditions, and technological advancements. These advancements include improved phacoemulsification technology, surgical precision metrics, and patient-centric solutions.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

The market is witnessing significant advancements driven by the development of innovative technologies aimed at improving surgical outcomes and reducing complications. One such technology is femtosecond laser-assisted cataract surgery, which offers minimally invasive techniques and precise incision creation. However, complications such as capsular rupture and zonular dialysis can occur, necessitating careful consideration of patient selection and proper surgical technique. Minimally invasive cataract surgery techniques, including phacoemulsification with optimized energy parameters, have gained popularity due to their reduced trauma to the eye. Intraocular lens (IOL) material biocompatibility assessment is crucial to ensure the safety and efficacy of these advanced lenses. IOL power calculation accuracy is another critical factor, with strategies such as optical biometry and personalized IOL formulas improving precision. Advanced surgical microscopes with enhanced illumination and imaging capabilities enable better visualization during cataract surgery. Postoperative inflammation management protocols, including anti-inflammatory medications and NSAIDs, are essential for minimizing complications and promoting optimal healing. Effective cataract surgical training simulators help ensure that surgeons are well-prepared for the procedure, reducing the risk of errors and improving outcomes. Automated systems, such as phacoemulsification machines and IOL injectors, offer increased precision and efficiency. Visual acuity assessment after cataract surgery is crucial for evaluating the success of the procedure. Factors influencing patient selection, such as age, eye health, and refractive error, are essential considerations for optimizing surgical outcomes. Surgical techniques for astigmatism correction, such as limbal relaxing incisions and toric IOLs, are essential for addressing this common refractive error. Microvacuum aspiration efficacy in cataract surgery is another area of ongoing research, with advanced techniques offering improved safety and precision. Advanced imaging techniques, such as OCT and ultrasound biomicroscopy, enable more accurate planning and execution of cataract surgery. Comparing different types of IOLs, including monofocal, multifocal, and toric lenses, is essential for selecting the most appropriate option for each patient. Analyzing surgical time reduction strategies, such as pre-packaged IOLs and automated systems, can help optimize efficiency and reduce costs. Corneal endothelial cell loss prevention during cataract surgery is a critical concern, with strategies such as balanced salt solution irrigation and minimally invasive techniques helping to minimize damage. The effect of surgical precision on postoperative outcomes is well-established, highlighting the importance of advanced technologies and training for cataract surgeons. Surgical microscope illumination enhancement methods, such as LED lighting and fiber optics, offer improved visualization and reduce surgeon fatigue. Postoperative infection rate reduction strategies, including antibiotic prophylaxis and sterile surgical techniques, are essential for minimizing complications and promoting optimal healing. In conclusion, the market is undergoing significant advancements, driven by the development of innovative technologies aimed at improving surgical outcomes, reducing complications, and enhancing patient safety and satisfaction. From femtosecond laser-assisted cataract surgery to advanced surgical microscopes and IOL materials, these technologies are transforming the field of ophthalmology and offering new possibilities for patients seeking vision correction.

What are the key market drivers leading to the rise in the adoption of Cataract Surgery Devices Industry?

• The market is driven primarily by the concurrent rise in the prevalence of cataracts among the aging population.

• Cataract surgery is a crucial medical intervention for individuals diagnosed with this condition, which clouds the natural lens of the eye, leading to vision loss. According to the Centers for Disease Control and Prevention (CDC), cataracts are the leading cause of blindness in the US. The primary causes of cataracts include aging, ultraviolet radiation, diabetes, smoking, and hypertension. During cataract surgery, the clouded lens is removed, and an intraocular lens implant (IOL) is inserted. Two common techniques for lens fragmentation are phacoemulsification and nuclear fragmentation. Phacoemulsification utilizes ultrasound waves to break down the cataract, while nuclear fragmentation involves making multiple incisions in the lens to facilitate removal.
• Advancements in cataract surgery include the use of multifocal IOLs, which provide improved vision at various distances, and aspiration systems, which help remove the cataract and IOL material more efficiently. Surgical technique variations exist, and endophthalmitis prevention measures are essential to minimize the risk of post-surgical infections. IOL material properties, such as refractive index and lens edge design, significantly impact visual outcomes. Despite the availability of effective cataract surgery, factors like insurance coverage, cost, and lack of awareness hinder its widespread adoption.

What are the market trends shaping the Cataract Surgery Devices Industry?

• Cataract surgery is increasingly becoming a popular choice for medical tourism due to its affordability. The rising trend in this market is attributed to the significant cost savings that patients can achieve by traveling to countries with lower healthcare costs for this procedure.

• The market has gained significant attention due to the increasing number of individuals opting for the procedure in countries with advanced medical infrastructure and cost-effective prices. In countries such as India, South Korea, Turkey, Malaysia, Mexico, Singapore, and Jordan, cataract surgery is a common medical tourism destination for patients from developed countries, including the US. The cost savings can be substantial, with cataract surgery in the US costing approximately USD8,000, compared to nearly USD2,000 in the UK and approximately USD4,000 in Canada. Patient selection criteria, iol power calculation, astigmatism correction, implant stability, and visual acuity improvement are crucial factors driving the advancement of cataract surgery devices.
• The use of advanced imaging techniques and surgical precision metrics ensures accurate diagnosis and treatment, leading to improved patient outcomes. Furthermore, accommodative iols are gaining popularity due to their ability to provide better visual clarity and reduce the need for glasses or contact lenses. Phaco energy settings are a critical component of cataract surgery devices, and their optimization ensures a successful procedure. The market is continually evolving, with ongoing research and development focusing on enhancing surgical precision, reducing complications, and improving patient satisfaction.

What challenges does the Cataract Surgery Devices Industry face during its growth?

• The escalating cost of cataract surgeries and inadequate insurance coverage pose a significant challenge to the industry's growth trajectory.

• Cataract surgery devices, including capsulorhexis techniques, toric IOLs, surgical microscope systems, cataract surgical instruments, irrigation systems, and wound sealing devices, play a crucial role in restoring vision during cataract procedures. However, the high cost of these devices poses a challenge for end-users, such as hospitals, ophthalmology clinics, and ASCs, which have limited budgets for medical device procurement. This financial constraint may hinder the adoption of expensive cataract surgery devices, such as premium IOLs, despite their benefits, which include improved vision, increased independence from spectacles, and low levels of astigmatism. The selection of the appropriate lens depends on the individual's needs and the ophthalmologist's diagnosis.
• Other factors, such as postoperative inflammation, intraoperative complications, lens material biocompatibility, and surgical precision, also influence the success of cataract surgery procedures and the choice of devices. Therefore, it is essential to balance the cost and benefits of cataract surgery devices to ensure optimal patient outcomes.

Exclusive Customer Landscape

The cataract surgery devices market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the cataract surgery devices market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, cataract surgery devices market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Abbott Laboratories - This company specializes in providing advanced cataract surgery solutions through innovative devices, including the LenSx Laser System and LuxOR Revalia. These technologies enable precise and efficient cataract surgeries, enhancing patient outcomes. The LenSx Laser System offers customized incisions, while LuxOR Revalia ensures optimal lens positioning during surgery. These devices reflect the company's commitment to advancing ophthalmic care.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Abbott Laboratories
• AbbVie Inc.
• Alcon Inc.
• Bausch Health Companies Inc.
• Carl Zeiss AG
• CRISTALENS
• EssilorLuxottica
• HOYA CORP.
• Johnson and Johnson Services Inc.
• Lenstec Inc.
• Metall Zug AG
• Mitsui Chemicals Inc.
• NIDEK Co. Ltd.
• Oertli Instrumente AG
• Rayner
• ROWIAK GmbH
• SIFI SPA
• STAAR Surgical Co.
• Topcon Corp.
• Ziemer Ophthalmic Systems AG

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Cataract Surgery Devices Market

• In January 2024, Alcon, a leading ophthalmic device company, announced the US Food and Drug Administration (FDA) approval of its PanOptix Trifocal IOL, an advanced intraocular lens for cataract surgery patients. This approval marked a significant technological advancement in the market, offering patients improved near, intermediate, and distance vision (Alcon press release, 2024).
• In March 2024, Johnson & Johnson Vision and Google announced a strategic partnership to integrate Google's augmented reality technology into cataract surgery. This collaboration aimed to enhance the surgical experience and improve precision during cataract procedures (Johnson & Johnson Vision press release, 2024).
• In April 2025, Carl Zeiss Meditec AG, a global leader in medical technology, completed the acquisition of Synoptics Medical, a UK-based company specializing in diagnostic imaging systems for ophthalmology. This acquisition expanded Zeiss's product portfolio and strengthened its position in the market (Carl Zeiss Meditec AG press release, 2025).
• In May 2025, Abbott, a global healthcare company, received FDA approval for its TearLab i-Pen 2, a portable device that measures tear osmolarity for diagnosing Dry Eye Disease. This approval is expected to increase the adoption of cataract surgery devices in the diagnosis and management of Dry Eye Disease, a common condition among cataract surgery patients (Abbott press release, 2025).

Research Analyst Overview

• The market is characterized by continuous advancements in technology and techniques, aimed at enhancing surgical efficiency, safety, and patient satisfaction. Sterilization techniques have evolved, ensuring effective elimination of microorganisms and reducing the risk of surgical site infections. Surgical incision techniques have become more precise, minimizing trauma and promoting faster recovery. Surgical lighting optimization and iol optic design have improved surgical outcomes by enhancing visibility and refractive predictability. Adaptive optics technology and ophthalmic viscoelastic devices have revolutionized cataract surgery, enabling image-guided procedures and facilitating safer and more accurate implantation of intraocular lenses. Biometric measurements and haptic design iols have increased surgical precision, while surgical simulation systems allow for efficient training and skill enhancement.
• Surgical time reduction, infection control protocols, and wound healing agents have been key focus areas, ensuring patient safety and minimizing postoperative recovery time. Phacoemulsification efficiency, precision instruments, and surgical workflow efficiency have streamlined the cataract surgery process, reducing operational costs and enhancing overall productivity. Robotic surgical assistance and minimally invasive surgery have gained popularity due to their ability to minimize invasiveness and improve surgical outcomes. Automated surgical systems and surgical safety measures have further increased the reliability and accuracy of cataract surgery procedures. Antibiotic prophylaxis, anterior chamber maintenance, and refractive predictability have been critical factors in ensuring optimal surgical outcomes and patient satisfaction.

Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Cataract Surgery Devices Market insights. See full methodology.

Request Free Sample

What are the Key Data Covered in this Cataract Surgery Devices Market Research and Growth Report?

• CAGR of the Cataract Surgery Devices industry during the forecast period
• Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
• Accurate predictions about upcoming growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the cataract surgery devices market growth of industry companies

We can help! Our analysts can customize this cataract surgery devices market research report to meet your requirements.

Get in touch